Cargando…

Objective evaluation of the role of vincristine in induction and maintenance therapy for myelomatosis. Medical Research Council Working Party on Leukaemia in Adults.

In the Medical Research Council's IVth trial in Myelomatosis the possible benefit of adding vincristine to first line treatment with intermittent melphalan and prednisone has been assessed. This was analysed in 530 patients who were randomly allocated to receive vincristine or not. Survival was...

Descripción completa

Detalles Bibliográficos
Autores principales:	MacLennan, I. C., Cusick, J.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1985
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977102/ https://www.ncbi.nlm.nih.gov/pubmed/3896288

Ejemplares similares

Prognostic features in the third MRC myelomatosis trial. Medical Research Council's Working Party on Leukaemia in Adults.
Publicado: (1980)

Treatment comparisons in the third MRC myelomatosis trial. Medical Research Council's Working Party on Leukaemia in Adults.
Publicado: (1980)

Report on the second myelomatosis trial after five years of follow-up. Medical Research Council's Working Party on Leukaemia in Adults.
Publicado: (1980)

A comparison of the incidence of the myelodysplastic syndrome and acute myeloid leukaemia following melphalan and cyclophosphamide treatment for myelomatosis. A report to the Medical Research Council's working party on leukaemia in adults.
por: Cuzick, J., et al.
Publicado: (1987)

Urinary pseudouridine excretion in myelomatosis.
por: Sørensen, S. H., et al.
Publicado: (1985)

The prognostic value of serum beta 2 microglobulin compared with other presentation features in myelomatosis.
por: Cuzick, J., et al.
Publicado: (1985)

A Case Report of Leptomeningeal Myelomatosis and Rapid Improvement with Regimen Consisting of Daratumumab, Pomalidomide, Vincristine, Procarbazine, and Dexamethasone
por: Kuan, Jew Win, et al.
Publicado: (2022)

Anaemia in patients with myelomatosis.
por: Ting, W. C., et al.
Publicado: (1982)

Plasma Cell Myelomatosis
por: Wahi, P. N., et al.
Publicado: (1946)

Rules of Procedure of the Council - Report by the Council Working Party
Publicado: (1968)

The late appearance of extramedullary lesions in myelomatosis.
por: Craft, I. L.
Publicado: (1967)

Surface antigens in acute myeloblastic leukaemia: a study using heterologous antisera.
por: Tupchong, L., et al.
Publicado: (1978)

Cytotoxic antibody in acute myeloblastic leukaemia during immunotherapy: lack of tumour specificity.
por: Gale, D. G., et al.
Publicado: (1977)

A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party.
por: Bleehen, N. M., et al.
Publicado: (1991)

Immunotherapy of acute myeloid leukaemia. Medical Research Council.
Publicado: (1978)

Dural Plasmacytoma with Meningeal Myelomatosis in a Patient with Multiple Myeloma
por: Gascón, Nieves, et al.
Publicado: (2018)

A trial of chemotherapy in patients with osteosarcoma (a report to the Medical Research Council by their Working Party on Bone Sarcoma.
Publicado: (1986)

A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). II: Quality of life. Medical Research Council Lung Cancer Working Party.
por: Bleehen, N. M., et al.
Publicado: (1993)

A Medical Research Council phase II trial of alternating chemotherapy and radiotherapy in small-cell lung cancer. The Medical Research Council Lung Cancer Working Party.
por: Bleehen, N. M., et al.
Publicado: (1991)

A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). I: Survival and prognostic factors. Medical Research Council Lung Cancer Working Party.
por: Bleehen, N. M., et al.
Publicado: (1993)

Analysis of treatment of childhood leukaemia. V. Advantage of reduced chemotherapy during and immediately after cranial irradiation.
por: MacLennan, I. C., et al.
Publicado: (1977)

Chemotherapy of acute myeloid leukaemia in adults: Medical Research Council.
Publicado: (1979)

Radiotherapy alone or with chemotherapy in the treatment of small-cell carcinoma of the lung. Medical Research Council Lung Cancer Working Party.
Publicado: (1979)

Serum beta 2-microglobulin in myelomatosis: potential value in stratification and monitoring.
por: Norfolk, D., et al.
Publicado: (1980)

Evaluation of serum beta 2-microglobulin as a prognostic indicator in myelomatosis.
por: Child, J. A., et al.
Publicado: (1983)

Potentiation of vincristine by vitamin A against drug-resistant mouse leukaemia cells.
por: Nogae, I., et al.
Publicado: (1987)

Draft Report by the Finance Committee and Recommendations to the Council on the Report of the Working Party on the CERN Programme and Budget
Publicado: (1962)

Progressive neurological deficits in multiple myeloma: meningeal myelomatosis without MRI abnormalities
por: van Ginkel, S., et al.
Publicado: (2011)

Working Parties
Publicado: (2017)

Synergistic inhibitory effects of dipyridamole and vincristine on the growth of human leukaemia and lymphoma cell lines.
por: Hirose, M., et al.
Publicado: (1987)

LYMPHOMATOSIS, MYELOMATOSIS, AND ENDOTHELIOMA OF CHICKENS CAUSED BY A FILTERABLE AGENT : I. TRANSMISSION EXPERIMENTS
por: Furth, J.
Publicado: (1933)

Symptoms at presentation for treatment in patients with lung cancer: implications for the evaluation of palliative treatment. The Medical Research Council (MRC) Lung Cancer Working Party.
por: Hopwood, P., et al.
Publicado: (1995)

What is the role of radiation-chemotherapy in the radical non-surgical management of carcinoma of the oesophagus? Upper GI Cancer Working Party of the UK Medical Research Council.
por: Price, P., et al.
Publicado: (1998)

The need for core outcome sets in urological cancer research
por: MacLennan, Steven, et al.
Publicado: (2021)

Inoperable non-small-cell lung cancer (NSCLC): a Medical Research Council randomised trial of palliative radiotherapy with two fractions or ten fractions. Report to the Medical Research Council by its Lung Cancer Working Party.
Publicado: (1991)

How Do We Meet the Supportive Care and Information Needs of Those Living With and Beyond Bladder Cancer?
por: MacLennan, Sara Jane, et al.
Publicado: (2020)

Case Report of Bone Marrow-Sparing Proton Therapy Craniospinal Irradiation for Central Nervous System Myelomatosis
por: Kauffmann, Greg, et al.
Publicado: (2017)

Assessment of quality of life in small-cell lung cancer using a Daily Diary Card developed by the Medical Research Council Lung Cancer Working Party.
por: Fayers, P. M., et al.
Publicado: (1991)

Working Party on Contracts Policy
Publicado: (1968)

Report of the ISR working party
por: CERN. Geneva
Publicado: (1976)

Cannot write session to /tmp/vufind_sessions/sess_nk2b8vj1qqp0t78oct9nc6gqng